Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Luc Balligand

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Cardiovascular Research|July 4, 2015
KLF6 orchestrates cardiac myocyte-to-fibroblast communication: 'He who has ears to hear, let him hear'Jean-Luc Balligand
Cardiovascular Research|August 11, 2012
Vitamin B or L-arginine supplementation in hyperhomocysteinaemia: think twice!Jean-Luc Balligand
Journal of the American College of Cardiology|April 25, 2009
beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?"Jean-Luc Balligand
Cardiovascular Research|August 24, 2013
Reducing damage through Nrf-2Jean-Luc Balligand
JACC. Cardiooncology|August 16, 2021
Cancer and Peripartum Cardiomyopathy: A Diabolic CoupleJean-Luc Balligand
Current Drug Delivery|September 25, 2012
Beta3-adrenoreceptors in cardiovasular diseases: new roles for an "old" receptorJean-Luc Balligand
Cardiovascular Research|March 23, 2016
Cardiac salvage by tweaking with beta-3-adrenergic receptorsJean-Luc Balligand
European Journal of Heart Failure|February 16, 2017
Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginningJean-Luc Balligand
Cardiovascular Research|November 14, 2018
Phosphatase regulatory subunits in beta-adrenergic signalling: a delicate balancing actJean-Luc Balligand
Cardiovascular Drug Reviews|June 19, 2002
Potential use of beta(3)-adrenoceptor antagonists in heart failure therapyStéphane Moniotte, Jean-Luc Balligand
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Cardiovascular Research|July 4, 2015
KLF6 orchestrates cardiac myocyte-to-fibroblast communication: 'He who has ears to hear, let him hear'Jean-Luc Balligand
Cardiovascular Research|August 11, 2012
Vitamin B or L-arginine supplementation in hyperhomocysteinaemia: think twice!Jean-Luc Balligand
Journal of the American College of Cardiology|April 25, 2009
beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?"Jean-Luc Balligand
Cardiovascular Research|August 24, 2013
Reducing damage through Nrf-2Jean-Luc Balligand
JACC. Cardiooncology|August 16, 2021
Cancer and Peripartum Cardiomyopathy: A Diabolic CoupleJean-Luc Balligand
Current Drug Delivery|September 25, 2012
Beta3-adrenoreceptors in cardiovasular diseases: new roles for an "old" receptorJean-Luc Balligand
Cardiovascular Research|March 23, 2016
Cardiac salvage by tweaking with beta-3-adrenergic receptorsJean-Luc Balligand
European Journal of Heart Failure|February 16, 2017
Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginningJean-Luc Balligand
Cardiovascular Research|November 14, 2018
Phosphatase regulatory subunits in beta-adrenergic signalling: a delicate balancing actJean-Luc Balligand
Cardiovascular Drug Reviews|June 19, 2002
Potential use of beta(3)-adrenoceptor antagonists in heart failure therapyStéphane Moniotte, Jean-Luc Balligand
Pageof 14